CAPITAL AND CODEINE Drug Patent Profile
When do Capital And Codeine patents expire, and what generic alternatives are available?
Capital And Codeine is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, and Carnrick. and is included in three NDAs.
The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capital And Codeine
A generic version of CAPITAL AND CODEINE was approved as acetaminophen; codeine phosphate by SUN PHARM INDS LTD on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CAPITAL AND CODEINE?
- What are the global sales for CAPITAL AND CODEINE?
- What is Average Wholesale Price for CAPITAL AND CODEINE?
Summary for CAPITAL AND CODEINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 71 |
| DailyMed Link: | CAPITAL AND CODEINE at DailyMed |
US Patents and Regulatory Information for CAPITAL AND CODEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 085883-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Valeant Pharms Llc | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | SUSPENSION;ORAL | 086024-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Carnrick | CAPITAL AND CODEINE | acetaminophen; codeine phosphate | TABLET;ORAL | 083643-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
